Analysts Set Markel Group Inc. (NYSE:MKL) PT at $2,100.00

Shares of Markel Group Inc. (NYSE:MKL) have received an average recommendation of “Hold” from the five analysts that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $2,100.00.

A number of research firms have commented on MKL. Truist Financial lifted their price objective on shares of Markel Group from $2,000.00 to $2,100.00 and gave the stock a “hold” rating in a report on Friday, February 6th. Weiss Ratings reissued a “buy (b+)” rating on shares of Markel Group in a report on Monday, December 29th. Zacks Research lowered shares of Markel Group from a “strong-buy” rating to a “hold” rating in a report on Monday, January 19th. Finally, Wall Street Zen raised shares of Markel Group from a “hold” rating to a “buy” rating in a research report on Saturday, March 14th.

Insider Buying and Selling

In other news, CEO Simon Wilson sold 100 shares of the stock in a transaction that occurred on Thursday, February 26th. The stock was sold at an average price of $2,079.48, for a total transaction of $207,948.00. Following the sale, the chief executive officer directly owned 2,397 shares in the company, valued at approximately $4,984,513.56. This represents a 4.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.66% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Markel Group

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Canerector Inc. raised its stake in shares of Markel Group by 191,036.0% in the 3rd quarter. Canerector Inc. now owns 10,703,616 shares of the insurance provider’s stock worth $20,458,463,000 after buying an additional 10,698,016 shares in the last quarter. Vanguard Group Inc. boosted its stake in Markel Group by 0.4% during the third quarter. Vanguard Group Inc. now owns 1,172,997 shares of the insurance provider’s stock valued at $2,242,020,000 after buying an additional 5,184 shares in the last quarter. Principal Financial Group Inc. grew its holdings in Markel Group by 1.8% during the third quarter. Principal Financial Group Inc. now owns 547,188 shares of the insurance provider’s stock worth $1,045,947,000 after acquiring an additional 9,496 shares during the period. Davis Selected Advisers grew its holdings in Markel Group by 11.1% during the fourth quarter. Davis Selected Advisers now owns 415,160 shares of the insurance provider’s stock worth $892,496,000 after acquiring an additional 41,632 shares during the period. Finally, Select Equity Group L.P. raised its position in Markel Group by 75.9% in the second quarter. Select Equity Group L.P. now owns 336,369 shares of the insurance provider’s stock worth $671,850,000 after acquiring an additional 145,146 shares in the last quarter. 77.12% of the stock is owned by institutional investors.

Markel Group Price Performance

Shares of MKL opened at $1,876.99 on Friday. Markel Group has a 52 week low of $1,621.89 and a 52 week high of $2,207.59. The company has a current ratio of 0.63, a quick ratio of 0.63 and a debt-to-equity ratio of 0.23. The firm has a market cap of $23.61 billion, a price-to-earnings ratio of 11.06 and a beta of 0.77. The stock has a 50 day moving average of $2,035.32 and a 200-day moving average of $2,022.29.

Markel Group Company Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.